LIDOCAÏNE ACCORD 10 mg/ml, solution for injection 10 ampoules of 5 ml
Active ingredients: Lidocaine hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection10 ampoules of 5 mlinfiltration;intramusculaire;intraveineuse;péridurale;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LIDOCAÏNE ACCORD 10 mg/mL, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- infiltration;intramusculaire;intraveineuse;péridurale;sous-cutanée
- Presentation description
- 10 ampoule(s) en verre de 5 ml
- Marketing authorisation holder
- ACCORD HEALTHCARE FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 28 Feb 2023
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65471110CIP73012786CIP133400930127865Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE LIDOCAÏNEsolution | 10 mg · 1 mL de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.